NASDAQ NMS - GLOBAL MARKET · NTHI

+2.04% · +$0.0700 · Vol 17.6K

After hours · updated 16:00:00 ET

NeOnc Technologies Holdings Inc

Pharmaceuticals

$3.50

Card

Relationship Map

Veridion Score

BETALOW CONF · 5/6 factors

Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET · NTHI

Methodology

NTHI

NeOnc Technologies Holdings Inc

Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET

26/100

AVOID

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

26/ 100

Veridion Score

AVOID · LOW confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: LOW · 5/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is NTHI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move NTHI next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Coverage building

No dated catalysts found for NTHI in the current source window. The page stays empty rather than inventing an event without a receipt.

About NeOnc Technologies Holdings Inc

PHARMACEUTICAL PREPARATIONS

Listed since

2025

Employees

Country

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$3.43

Day high

$3.57

Day low

$3.43

Previous close

$3.43

52W high

$12.09

-71.05% from high

52W low

$3.25

3% of range

Market cap

$88.9M

EPS

$-3.2300

Beta

-0.17

Shares out

25.9M

Volume

17.6K

0.29× rel vol

Avg volume

61.5K

VWAP

$3.50

Price history computed in-house

0.00%

-21.70%

-46.07%

-25.77%

YTD

-57.68%

SMA 50 $4.23 · below

SMA 200 $7.11 · below

52W position 3%

NTHI overview

Veridion Score

5 of 6 factors measured

Congress receipts

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around NTHI.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

NTHI insider activity

NeOnc Technologies Holdings Inc

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

No value-bearing Form 4 rows

The current Form 4 feed did not return value-bearing open-market rows for NTHI.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in NTHI

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NTHI in the cached public ledger.

Federal contracts

NTHI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for NTHI in this window.

Lobbying spend

NTHI lobbying filings, year to date.

Registered lobbying filings matched to NeOnc Technologies Holdings Inc.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for NTHI in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for NTHI.

Options

Sovereign unlock shows live options positioning for NTHI.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Why is NTHI moving today?

What can move NTHI next.

NTHI overview

Related filings and maps

NTHI insider activity

NTHI contract awards, year to date.

NTHI lobbying filings, year to date.

Cross-references from this score page.

What can move NTHI next.

NTHI insider activity

Cross-references from this score page.